Celiac Disease Foundation (CDF) – the nation’s leading disease advocacy organization for celiac disease – has received a prestigious Service Grant from The Taproot Foundation, valued at $45,000, to produce its annual report, in celebration of the Foundation’s 25th anniversary.
Celiac Disease Foundation is pleased to announce our participation in the Autoimmune Research Registry, known as ARNet. ARNet is a network of autoimmune disease advocacy organizations that will foster research into celiac disease and related autoimmune conditions. In consonance with CDF’s Strategic Plan to increase national awareness of the ramifications of undiagnosed celiac disease, the first goal of […]
Underscoring its role as a leader in online tools for the gluten-free community, Celiac Disease Foundation (CDF) today launched the Gluten-Free Allergy-Free Marketplace, a new retail destination hosted on celiac.org. Featured at celiac.org/marketplace, the Marketplace showcases products and services from companies that care about the gluten-free and allergy-free community, and have made a deep commitment […]
Celiac Disease Foundation is pleased to announce the March 30-31, 2015, U.S. Food and Drug Administration (FDA) public workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3). This scientific meeting will address endpoints and outcome measures for clinical trials for products intended to treat adult and/or pediatric celiac disease and inflammatory bowel disease.
On March 23rd, join CDF at The State of Autoimmune Disease: A National Summit at the National Press Club in Washington, DC. The summit will bring together leading experts in research, environment, advocacy and patient issues to explore the most current trends in autoimmune disease diagnosis, treatments and therapies.
Celiac Disease Foundation, the nation’s leading voluntary health organization for celiac disease, announces the appointment of four new members of its Board of Directors for the 2015-2017 term. Joining the Board of Director are Emily Luxford, Jody Morris, Jordan Ramer, and Jim Watson.
Currently, the typical treatment for a patient diagnosed with celiac disease is a strict gluten-free diet for life. Future therapies currently in the pipeline hope to make living with celiac disease less of a burden.
Learn from experts from the Celiac Program at Harvard Medical School at the inaugural CEU-based medical and nutrition conference titled “Gluten Free for Life: A Comprehensive Toolkit for Diagnosing and Treating Celiac Disease and Other Gluten-Related Disorders” with separate healthcare professionals and patient tracks.